APA (7th ed.) Citation

Aurer, I., Nemet, D., Mitrović, Z., Dujmović, D., Bašić-Kinda, S., Radman, I., . . . Labar, B. (2016). High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin's lymphoma. Annals of Hematology, 95(7), 1129. https://doi.org/10.1007/s00277-016-2676-0

Chicago Style (17th ed.) Citation

Aurer, Igor, et al. "High-dose Ifosfamide and Mitoxantrone (HDIM) in Patients with Relapsed or Refractory Hodgkin's Lymphoma." Annals of Hematology 95, no. 7 (2016): 1129. https://doi.org/10.1007/s00277-016-2676-0.

MLA (9th ed.) Citation

Aurer, Igor, et al. "High-dose Ifosfamide and Mitoxantrone (HDIM) in Patients with Relapsed or Refractory Hodgkin's Lymphoma." Annals of Hematology, vol. 95, no. 7, 2016, p. 1129, https://doi.org/10.1007/s00277-016-2676-0.